Dr Carel Oosthuizen

Carel is a biologist with a background in ethnopharmacology and mycobacteriology.

He completed his PhD at the University of Pretoria under the supervision of Prof Namrita Lall, investigating the antimycobacterial and quorum quenching potential of quinoline derivatives. Carel has ample experience in the field of phytochemistry, biochemistry, microbiology, enzymology and computational biology, with a special interest in mycobacterial biofilm inhibition. During his studies, Carel was invited as a visiting scientist to the University of Albany, New York, and the University of East Anglia, UK, where he investigated the inhibition of Mycobacterial biofilms and gained insights into the kinetics of mycothione reductase inhibitors, respectively. During his postdoc, Carel worked on discovering quorum quenching inhibitors and developing new assays for screening purposes. Carel has a passion for education and has mentored and supervised several postgraduate students at honours and Masters level. Carel joined H3D as an AMR investigator to establish and elaborate on the capabilities of the platform and enhance the overall impact of drug discovery efforts in the field of antimicrobial resistance.